An Assistant Secretary at the US Department of Health and Human Services has backed the Trump administration’s efforts to restrict federal funding for gender-related medical treatment for minors. The official argued that care for young people with gender dysphoria should prioritise mental-health support and compassionate care, warning that some medical interventions may carry long-term or irreversible effects.

The article identifies the official as Adm. Brian Christine, who criticised the use of puberty blockers, cross-sex hormones and surgery for minors. It presents the policy dispute as part of a broader Trump administration crackdown on federally funded youth gender procedures, although the supplied text does not specify the exact funding rules or their implementation date.